1. Home
  2. BIO vs KBR Comparison

BIO vs KBR Comparison

Compare BIO & KBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BIO
  • KBR
  • Stock Information
  • Founded
  • BIO 1952
  • KBR 1901
  • Country
  • BIO United States
  • KBR United States
  • Employees
  • BIO N/A
  • KBR N/A
  • Industry
  • BIO Biotechnology: Laboratory Analytical Instruments
  • KBR Military/Government/Technical
  • Sector
  • BIO Industrials
  • KBR Industrials
  • Exchange
  • BIO Nasdaq
  • KBR Nasdaq
  • Market Cap
  • BIO 6.0B
  • KBR 6.3B
  • IPO Year
  • BIO N/A
  • KBR 2006
  • Fundamental
  • Price
  • BIO $243.98
  • KBR $47.94
  • Analyst Decision
  • BIO Strong Buy
  • KBR Buy
  • Analyst Count
  • BIO 4
  • KBR 7
  • Target Price
  • BIO $324.25
  • KBR $68.33
  • AVG Volume (30 Days)
  • BIO 417.7K
  • KBR 1.4M
  • Earning Date
  • BIO 07-31-2025
  • KBR 07-23-2025
  • Dividend Yield
  • BIO N/A
  • KBR 1.38%
  • EPS Growth
  • BIO N/A
  • KBR N/A
  • EPS
  • BIO N/A
  • KBR 2.98
  • Revenue
  • BIO $2,541,100,000.00
  • KBR $7,979,000,000.00
  • Revenue This Year
  • BIO N/A
  • KBR $14.27
  • Revenue Next Year
  • BIO $3.49
  • KBR $8.57
  • P/E Ratio
  • BIO N/A
  • KBR $16.10
  • Revenue Growth
  • BIO N/A
  • KBR 12.84
  • 52 Week Low
  • BIO $211.43
  • KBR $43.89
  • 52 Week High
  • BIO $387.99
  • KBR $72.60
  • Technical
  • Relative Strength Index (RSI)
  • BIO 60.94
  • KBR 33.76
  • Support Level
  • BIO $235.01
  • KBR $47.69
  • Resistance Level
  • BIO $246.50
  • KBR $49.47
  • Average True Range (ATR)
  • BIO 7.17
  • KBR 1.25
  • MACD
  • BIO 2.32
  • KBR -0.45
  • Stochastic Oscillator
  • BIO 90.49
  • KBR 13.72

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

About KBR KBR Inc.

KBR, formerly Kellogg Brown & Root, is global provider of technology, integrated engineering, procurement, and construction delivery, and operations and maintenance services. The company's business is organized into two segments: government solutions and sustainable technology solutions. KBR has operations in over 30 countries and employs approximately 34,000 people. The firm generated $7.7 billion in revenue in 2024.

Share on Social Networks: